VerdeMed Holdings

VerdeMed is a pharmaceutical company dedicated to providing high-quality medical cannabis products to the Latin American market. Based in Toronto, Canada, the company utilizes international standards to develop and distribute cannabinoid-based medications that meet rigorous pharmaceutical requirements. Their primary focus is on the Brazilian, Mexican, and Colombian markets, where they offer a range of CBD and THC formulations. VerdeMed targets a variety of therapeutic areas, including neurology, chronic pain management, and psychiatry. By partnering with GMP-certified manufacturers globally, the company ensures a reliable supply of medical-grade cannabis for patients in need. Their business model combines Canadian expertise in cannabis regulation with deep local knowledge of Latin American healthcare systems.